How axing pathology bulk-billing incentives will hit patient care

Is the long-standing funding agreement the pathology sector has enjoyed with successive governments being torn up? Australian Doctor investigates.

For a health minister who recently offered to consult with ‘stakeholders' over a cuppa, Sussan Ley seems to have had no time for an Earl Grey with pathologists.

Her announcement that bulk-billing incentives for pathology are to be abolished in July 2016 came out of the blue in the week before Christmas, as part of her government's mid-year economic and fiscal outlook